Highlights

  • Amkor Technology jumped over 17% after Q3 results and new Arizona facility plans.
  • Lumen Technologies surged 15% as quarterly loss narrowed and major PCF contracts were secured.
  • IDEXX Laboratories climbed nearly 15% on upbeat earnings and raised full-year revenue guidance.
  • Freshpet gained 14% following Q3 revenue growth and a higher profitability outlook.
  • Semiconductor, communications, and consumer segments led overall U.S. market momentum.

U.S. equities closed higher yesterday, with several companies across technology, communications, and consumer sectors recording notable price gains. The session reflected notable attention toward firms showing positive earnings updates, business expansion, and structural demand resilience across varied industries.

Amkor Technology, Inc. (NASDAQ:AMKR)

Amkor Technology’s shares increased more than 14% after the company released its third-quarter 2025 financial results. The semiconductor packaging and test provider reported quarterly revenue of USD 1.73 billion and net income of USD 172 million, with earnings per share of USD 0.67.

Amkor also announced the start of construction on a new advanced packaging and test facility in Peoria, Arizona, expected to begin production in 2028. The investment aims to support domestic semiconductor manufacturing capacity.

In addition, the board approved a CEO transition plan, with Giel Rutten stepping down and Jim Jansen appointed as the new president and chief executive officer effective January 2026.

Lumen Technologies, Inc. (NYSE:LUMN)

Lumen Technologies gained about 15% after reporting a smaller third-quarter loss than expected. The company posted revenue of USD 3.09 billion, compared with USD 3.07 billion a year earlier, supported by growth in its enterprise connectivity segment.

Lumen stated that it secured over USD 10 billion in new Private Connectivity Fabric (PCF) contracts, including a USD 1 billion multi-year agreement in October 2025. The company is also divesting non-core consumer operations to reduce debt and concentrate on network infrastructure and business connectivity.

IDEXX Laboratories, Inc. (NASDAQ:IDXX)

IDEXX Laboratories’ stock rose nearly 15% following its third-quarter 2025 results. The veterinary diagnostics firm reported revenue of USD 1.105 billion, an increase of 13% year-on-year, and diluted EPS of USD 3.40, which was above analyst projections.

The company revised its full-year outlook to revenue between USD 4.27 billion and USD 4.30 billion, and adjusted EPS between USD 12.81 and USD 13.01. Management attributed the performance to higher recurring revenue from diagnostic services and equipment placements.

Freshpet, Inc. (NASDAQ:FRPT)

Freshpet shares advanced 14% after the company reported third-quarter 2025 revenue of USD 264.5 million, up 14% from the prior year. Net income was USD 101.7 million, compared with USD 11.9 million in the same quarter last year.
Freshpet maintained its focus on improving profitability, noting that operating expenses as a percentage of sales decreased from the previous year. The company expects full-year adjusted EBITDA in the range of USD 190 million to USD 195 million and continued free-cash-flow generation.